551 related articles for article (PubMed ID: 17696960)
1. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
Anan F; Masaki T; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Umeno Y; Okada K; Wakasugi K; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
[TBL] [Abstract][Full Text] [Related]
2. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone reduces blood pressure in non-dipping diabetic patients.
Negro R; Dazzi D; Hassan H; Pezzarossa A
Minerva Endocrinol; 2004 Mar; 29(1):11-7. PubMed ID: 15258553
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
5. Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?
Afsar B; Sezer S; Elsurer R; Ozdemir FN
Blood Press Monit; 2007 Jun; 12(3):133-9. PubMed ID: 17496462
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients.
Della Mea P; Lupia M; Bandolin V; Guzzon S; Sonino N; Vettor R; Fallo F
Am J Hypertens; 2005 Jan; 18(1):30-5. PubMed ID: 15691614
[TBL] [Abstract][Full Text] [Related]
7. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and blood pressure circadian variation in an obese hypertensive population.
Diamantopoulos EJ; Andreadis E; Tsourous G; Katsanou P; Georgiopoulos D; Fotia M; Antoniou A; Raptis SA
Clin Exp Hypertens; 2006 Oct; 28(7):625-30. PubMed ID: 17060061
[TBL] [Abstract][Full Text] [Related]
9. The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives.
Inanc T; Kaya MG; Yarlioglues M; Ardic I; Ozdogru I; Dogan A; Kalay N; Gunturk E; Gunebakmaz O; Gul I; Topsakal R
Blood Press; 2010 Apr; 19(2):81-5. PubMed ID: 20367545
[TBL] [Abstract][Full Text] [Related]
10. "Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study.
Timio M; Venanzi S; Lolli S; Lippi G; Verdura C; Monarca C; Guerrini E
Clin Nephrol; 1995 Jun; 43(6):382-7. PubMed ID: 7554522
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
12. Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension.
Tsioufis C; Syrseloudis D; Dimitriadis K; Thomopoulos C; Tsiachris D; Pavlidis P; Selima M; Kallikazaros I; Stefanadis C
J Hum Hypertens; 2008 Jul; 22(7):501-8. PubMed ID: 18385743
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance index as a predictor for pioglitazone treatment in type 2 diabetes.
Araki T; Emoto M; Yokoyama H; Motoyama K; Morioka T; Tahara H; Koyama H; Shoji T; Okuno Y; Inaba M; Nishizawa Y
Osaka City Med J; 2005 Jun; 51(1):19-25. PubMed ID: 16334613
[TBL] [Abstract][Full Text] [Related]
14. An assessment of blood pressure measurement in a diabetic clinic using random-zero, semi-automated, and 24-hour monitoring.
Sturrock ND; Pound N; Peck GM; Soar CM; Jeffcoate WJ
Diabet Med; 1997 May; 14(5):370-5. PubMed ID: 9171252
[TBL] [Abstract][Full Text] [Related]
15. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension.
Uzu T; Kimura G
Circulation; 1999 Oct; 100(15):1635-8. PubMed ID: 10517735
[TBL] [Abstract][Full Text] [Related]
16. QT dispersion in type 2 diabetic patients with altered diurnal blood pressure rhythm.
Deyneli O; Ersöz HO; Yavuz D; Fak AS; Akalin S
Diabetes Obes Metab; 2005 Mar; 7(2):136-43. PubMed ID: 15715886
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of nocturnal blood pressure fall in early phases of untreated essential hypertension: a prospective observational study.
Cuspidi C; Meani S; Salerno M; Valerio C; Fusi V; Severgnini B; Lonati L; Magrini F; Zanchetti A
J Hum Hypertens; 2004 Jul; 18(7):503-9. PubMed ID: 14749713
[TBL] [Abstract][Full Text] [Related]
18. [Reduced nocturnal systolic blood pressure dip in obese children].
Ruiz Pons M; García Nieto V; García MG; García Mérida M; Valenzuela Hdez C; Aguirre-Jaime A
Nefrologia; 2008; 28(5):517-24. PubMed ID: 18816210
[TBL] [Abstract][Full Text] [Related]
19. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study.
Covic A; Mititiuc I; Gusbeth-Tatomir P; Goldsmith DJ
J Nephrol; 2002; 15(5):497-506. PubMed ID: 12455715
[TBL] [Abstract][Full Text] [Related]
20. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
